C12N 2740/15052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2740/15052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 70 US grants and 170 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 170
- Assignees
- 107
- Inventors
- 353
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 5 |
| 2004 | 2 | 2 |
| 2005 | 2 | 6 |
| 2006 | 3 | 3 |
| 2007 | 4 | 5 |
| 2008 | 1 | 4 |
| 2009 | 2 | 3 |
| 2010 | 3 | 1 |
| 2011 | 0 | 2 |
| 2012 | 3 | 3 |
| 2013 | 1 | 2 |
| 2014 | 2 | 3 |
| 2015 | 1 | 4 |
| 2016 | 1 | 4 |
| 2017 | 0 | 3 |
| 2018 | 4 | 5 |
| 2019 | 3 | 10 |
| 2020 | 3 | 8 |
| 2021 | 3 | 10 |
| 2022 | 2 | 8 |
| 2023 | 8 | 15 |
| 2024 | 6 | 29 |
| 2025 | 11 | 17 |
| 2026 | 2 | 16 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Spike-in reference standard for use in detecting sample target from DNA or RNA organism26 May 2026US 12,637,726 B2Gene Copoeia, Inc.
- Viral and non-viral nanoplasmid vectors with improved production14 Apr 2026US 12,600,984 B2Aldevron, LLC
- Chimeric antigen receptor targeting CLL1 and use thereof30 Dec 2025US 12,508,312 B2Guangzhou Bio-Gene Technology Co., Ltd
- Pre-immunization and immunotherapy29 Jul 2025US 12,370,253 B2American Gene Technologies International Inc.
- Engineered enveloped vectors and methods of use thereof29 Jul 2025US 12,371,689 B2GigaMune, Inc.
- Production of cells and viral vectors8 Oct 2026US 2026/0308612 A1Biocell Innovations Pte., Ltd.
- Purification of viruses and viral like particles8 Oct 2026US 2026/0308616 A1Interius Biotherapeutics, Inc.
- Modular re-targeting of rhabdoviral (g) glycoproteins from their natural receptors24 Sep 2026US 2026/0285912 A1Vyriad, Inc.
- Viral and non-viral nanoplasmid vectors with improved production24 Sep 2026US 2026/0286384 A1Aldevron, LLC
- Vector production24 Sep 2026US 2026/0286391 A1Fondazione Telethon Ets
Most cited
By later US patents
- Lentivirus vector system92US 6,790,657 B1The United States of America as represented by the Department of Health and Human Services · 2004
- Lentivirus-based gene transfer vectors50US 6,277,633 B1The University of North Carolina at Chapel Hill · 2001
- CCR7 ligand delivery and co-delivery in immunotherapy27US 8,592,364 B2Ecole Polytechnique Federale De Lausanne (Epfl) · 2013
- HIV pre-immunization and immunotherapy25US 10,036,038 B2American Gene Technologies International Inc. · 2018
- HIV pre-immunization and immunotherapy25US 10,233,464 B2American Gene Technologies International Inc. · 2019